Uniplan Investment Counsel’s Amgen AMGN Stock Holding History

Uniplan Investment Counsel’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.41M	Sell	9,677 -414	-4%	-$148K	0.35%	75
2025 Q4	$3.3M	Buy	10,091 +2,267	+29%	+$719K	0.33%	81
2025 Q3	$2.21M	Sell	7,824 -412	-5%	-$119K	0.22%	109
2025 Q2	$2.3M	Sell	8,236 -684	-8%	-$194K	0.23%	100
2025 Q1	$2.78M	Sell	8,920 -187	-2%	-$55.2K	0.27%	92
2024 Q4	$2.37M	Sell	9,107 -427	-4%	-$127K	0.22%	97
2024 Q3	$3.07M	Sell	9,534 -676	-7%	-$221K	0.27%	84
2024 Q2	$3.19M	Sell	10,210 -232	-2%	-$68.2K	0.29%	80
2024 Q1	$2.97M	Sell	10,442 -1,481	-12%	-$433K	0.23%	86
2023 Q4	$3.44M	Buy	+11,923	New	+$3.25M	0.26%	80

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Uniplan Investment Counsel's AMGN Position: Q1 2026 in Review

Uniplan Investment Counsel reduced its Amgen (AMGN) stake by 4.1% in Q1 2026, selling an estimated $148K and leaving 9,677 shares worth $3.41M. The position accounts for 0.35% of the portfolio, ranked #75.

Uniplan Investment Counsel first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.44M in Q4 2023. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Uniplan Investment Counsel held 9,677 shares of Amgen worth $3.41M as of Q1 2026.
Uniplan Investment Counsel sold 414 Amgen shares in Q1 2026, an estimated $148K.
Amgen made up 0.35% of Uniplan Investment Counsel's portfolio in Q1 2026, its #75 holding.
Uniplan Investment Counsel first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
Uniplan Investment Counsel's Amgen position peaked at $3.44M in Q4 2023.
3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Uniplan Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.